logo-full arrow-left arrow-right magnify story members projects twitter facebook youtube download

New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention Options By Marc-André LeBlanc, Founding member of IRMA

International Rectal Microbicide Advocates (IRMA) and our many partners and allies believe we need an array of HIV prevention options. There has been enormous progress in the field of HIV prevention research in recent years. The remarkably high efficacy of antiretroviral drugs (ARVs) for prevention has been demonstrated, both for oral pre-exposure prophylaxis ( PrEP, now approved and subsidized in several countries ) and through treatment leading to viral suppression or “undetectability” ( U=U, Undetectable = Untransmittable ).

Microbicide—products that could be used vaginally or rectally to reduce a … Lire la suite 


 

40 th UNAIDS PCB Thematic Segment: HIV Prevention 2020: A Global Partnership for Delivery Panel: What is required for prevention scale-up Delivered by: Robin Montgomery, Interagency Coalition on AIDS and Development (ICAD) I speak on behalf of the Interagency Coalition on AIDS and Development (ICAD) – a Consortium of over 100 Canadian-based front-line and international development partners, community leaders and advocates. Thank you very much to our esteemed panelists and to the working group who have organized today’s very important thematic segment. One issue we haven’t heard about today – but yet constitutes a key driver of new infections around the world – is the growing level of HIV complacency. … Lire la suite